Girdin protein: A potential metastasis predictor associated with prognosis in lung cancer
Authors:
Open Access
- 19 January 2018
- journal article
- research article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 15 (3) , 2837-2843
Abstract
The present study explored the relationship between Girdin protein expression and the survival rate of patients with lung carcinoma. A total of 334 lung cancer specimens, 20 benign lung disease tissue sections and 24 fresh tissues from patients with lung carcinoma were analyzed by immunohistochemistry and western blotting. Girdin protein was expressed in 130/334 (38.93%) of the cases examined. Girdin protein expression was correlated with tumor/node/metastasis stage (P<0.001), lymph node metastasis (P=0.001), distant metastasis (P<0.001) and specimen sites (P=0.034). Girdin expression was also correlated with signal transducer and activator of transcription 3 (STAT3) expression (P<0.001). Patients with high Girdin and STAT3 expression had a significantly poorer prognosis compared with those with low/high, high/low or low/low expression (P<0.001). In summary, Girdin may be a prognostic marker of lung cancer and serve as a biomarker for metastasis.Keywords
This publication has 27 references indexed in Scilit:
- Girdin, a regulator of cell motility, is a potential prognostic marker for esophageal squamous cell carcinomaOncology Reports, 2013
- Tracking metastasis and tricking cancerNature, 2013
- STAT3 Protein Up-regulates Gα-interacting Vesicle-associated Protein (GIV)/Girdin Expression, and GIV Enhances STAT3 Activation in a Positive Feedback Loop during Wound Healing and Tumor Invasion/MetastasisJournal of Biological Chemistry, 2012
- Involvement of Girdin in the Determination of Cell Polarity during Cell MigrationPLOS ONE, 2012
- Girdin protein: a new potential distant metastasis predictor of breast cancerMedical Oncology, 2011
- Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cellsOncogene, 2011
- Survival by histologic subtype in stage IV nonsmall cell lung cancer based on data from the Surveillance, Epidemiology and End Results ProgramClinical Epidemiology, 2011
- Expression of GIV/Girdin, a metastasis‐related protein, predicts patient survival in colon cancerThe FASEB Journal, 2010
- The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant TumoursJournal of Thoracic Oncology, 2007
- Akt/PKB Regulates Actin Organization and Cell Motility via Girdin/APEDevelopmental Cell, 2005